PROBLEMATIC REGURGITATION DESPITE POTENT ACID SUPPRESSION AND HEARTBURN RELIEF IN PATIENTS WITH NON-EROSIVE REFLUX DISEASE OR REFLUX OESOPHAGITIS

(1) AstraZeneca R&D

(2) Oxford PharmaGenesis™ Ltd

(3) NORTHWESTERN UNIVERSITY



This item was part of the Oesophageal, Gastric and Duodenal Disorders II session at UEG Week Stockholm 2011

This item can be cited as: Gut 2011; 60 (Suppl 3) A267